Further research is needed to fully understand the therapeutic potential of Agens 128 and to advance its development as a treatment for chronic inflammatory diseases. Conclusion In conclusion, this study provides evidence to support the efficacy of Agens 128 in treating chronic inflammation in a preclinical model. The reduction in inflammatory markers and tissue damage, as well as the improvement in behavior and physical condition, indicate that Agens 128 has significant anti-inflammatory prope...